In treating dyspepsia, the inclusion of probiotics alongside antibiotics proves beneficial due to their distinctive roles. While antibiotics target and eliminate specific harmful bacteria like Helicobacter pylori, probiotics contribute to gut health by restoring a balanced microbial environment. Probiotics help mitigate antibiotic-associated side effects, such as bloating and nausea, and support immune function, offering a more holistic and gentler approach to dyspepsia treatment. This combination not only addresses the root cause of infection but also promotes overall digestive well-being, potentially reducing the likelihood of recurrence. In this context, Lacidofil Strong by Lallemand, stands out as an effective adjuvant to antibiotics for the treatment of dyspepsia. The study, involving 90 patients, highlights its potential as a potent adjuvant to antibiotics. Key Findings: H. pylori Eradication Rates: 90.9% eradication rate, surpassing the 75% rate with a placebo. Reduced Side Effects: Significantly reduced treatment side effects bloating, nausea, and bitter taste improving overall tolerability. Enhanced Well-being: After just 14 days, the probiotic group reported lower gastrointestinal symptom scores and higher SF-36 health-related quality of life scores compared to the placebo demonstrating its role in advancing the landscape of digestive health interventions
Source: https://www.frontiersin.org/articles/10.3389/fgstr.2023.1245993/full
